# US 8,278,102 B2 · Viable cells from frozen umbilical cord tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,102 B2
- Document ID: US8278102B2
- Status: Granted
- Kind: B2
- Application number: 12/158,616
- Filed: 2006-12-21
- Published: 2009-11-05
- Granted: 2012-10-02
- Earliest claimed: 2005-12-22
- Inventors: Jane Ennis; Rahul Sarugaser; John E. Davies
- Web page: https://patentgrep.com/patent/US8278102B2

## CPC

- A01N 1/10: Preservation of living parts
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A61K 35/44: Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Viable progenitor cells are extracted from frozen umbilical cord tissue. In embodiments, the umbilical cord tissue is a blood vessel bearing perivascular Wharton's jelly, and the extracted progenitor cells are HUCPVCs.

## Claims

### Claim 1

A method for recovering viable progenitor cells from cryogenically frozen umbilical cord tissue, comprising the steps of:
i) thawing the cord tissue, wherein the cord tissue is an umbilical cord blood vessel, or a segment thereof, bearing perivascular Wharton's jelly comprising said progenitor cells and a cryopreserving solution comprising a serum-containing medium and a cryopreservant, and wherein, prior to cryogenic freezing, the cord tissue is contacted with said cryopreserving solution by the step consisting of immersing said cord tissue in said cryopreserving solution to allow passive permeation about the exterior of said cord tissue with said cryopreserving solution,
ii) displacing the cryopreservant with an aqueous liquid; and
iii) recovering said viable progenitor cells from the cord tissue so treated.

### Claim 2 (depends on 1)

The method of claim 1, wherein the cryopreservant is dimethyl sulfoxide (DMSO).

### Claim 3 (depends on 1)

The method of claim 1, wherein the cell culturing medium comprises fetal bovine serum or human serum.

### Claim 4 (depends on 1)

The method of claim 1, wherein the cryopreserving solution comprises, by volume, 1-25% DMSO and 75-99% of said.

### Claim 5 (depends on 4)

The method of claim 4, wherein the cryopreserving solution comprises 10% DMSO and 90% of said medium.

### Claim 6 (depends on 1)

The method of claim 1, wherein the umbilical cord tissue is human umbilical cord tissue.

### Claim 7 (depends on 1)

The method of claim 1, wherein the umbilical cord tissue is essentially free from blood.

### Claim 8 (depends on 1)

The method of claim 1, wherein the thawing process is performed at about 37° C.

### Claim 9 (depends on 1)

The method of claim 1, wherein the thawed cord is treated by immersion in water or buffer at about 4° C.

### Claim 10 (depends on 1)

The method of claim 1, wherein the viable cells recovered from the stored cord tissue are human umbilical cord perivascular cells.

### Claim 11 (depends on 10)

The method of claim 10, wherein the viable cells are recovered by digestion of the Wharton's jelly.

### Claim 12 (depends on 1)

The method of claim 1, wherein, after contacting of said cord tissue with said cryopreserving solution and prior to said cryogenic freezing, the cord tissue is subjected to a cooling process in which the cord tissue is refrigerated in the cryopreserving solution in liquid form for a period of time and at a temperature permitting the cryopreservant to penetrate exterior portions of the cord tissue, and freezing the cooled cord tissue to produce the frozen umbilical cord tissue.

### Claim 13 (depends on 12)

The method of claim 12 further comprising storing the frozen umbilical cord tissue under cryogenic conditions.

### Claim 14 (depends on 13)

The method of claim 13, wherein the cryogenic storage is conducted at about −196° C.

### Claim 15 (depends on 12)

The method of claim 12, wherein the refrigerating is performed at about 4° C. for a period of at least 20 minutes.

### Claim 16 (depends on 12)

The method of claim 12, wherein the freezing is conducted at about −70° C.

### Claim 17 (depends on 1)

The method of claim 1, wherein the aqueous liquid is water or buffered saline.

### Claim 18

A method for recovering viable human umbilical cord perivascular cells (HUCPVCs) from cryogenically frozen umbilical cord tissue, comprising the steps of:
i) thawing the cord tissue, wherein the cord tissue is a human umbilical cord blood vessel, or segment thereof, bearing viable cells within associated perivascular Wharton's jelly comprising progenitor cells and a cryopreserving solution comprising a serum-containing medium and dimethyl sulfoxide (DMSO), and wherein, prior to cryogenic freezing, the cord tissue is contacted with said cryopreserving solution by the step consisting of immersing said cord tissue in said cryopreserving solution to allow passive permeation about the exterior of said cord tissue with said cryopreserving solution;
ii) displacing the DMSO with an aqueous liquid; and
iii) digesting the Wharton's jelly associated with the cord tissue to release said viable HUCPVCs from the cord tissue.

### Claim 19 (depends on 18)

The method of claim 18, wherein the umbilical cord tissue was freshly obtained post-partum tissue when frozen.

### Claim 20 (depends on 18)

The method of claim 18, wherein, after contacting of said cord tissue with said cryopreserving solution and prior to said cryogenic freezing, said cord tissue is subjected to a cooling process in which the cord tissue is refrigerated in the cryopreserving solution in liquid form for a period of time and at a temperature permitting the DMSO to penetrate exterior portions of the cord tissue, and freezing the cooled cord tissue under cryogenic conditions, and wherein, prior said thawing, said cord tissue is stored under said cryogenic conditions for a period of time.
